Factors influencing participation rates in clinical late‐effect studies of childhood cancer survivors

Autor: Anne Sophie Lind Helligsoe, Henrik Hasle, Christian Dehlendorff, Jeanette Falck Winther, Line Kenborg, Louise Tram Henriksen
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Helligsø, A S L, Henriksen, L T, Kenborg, L, Dehlendorff, C, Winther, J F & Hasle, H 2021, ' Factors influencing participation rates in clinical late-effect studies of childhood cancer survivors ', Pediatric Blood & Cancer, vol. 68, no. 9, e29098 . https://doi.org/10.1002/pbc.29098
DOI: 10.1002/pbc.29098
Popis: To ensure external validation of a study population in clinical late-effect studies of childhood cancer, the participation rate must be high. This study investigated demographic data in Nordic late-effect studies and potential factors impacting participation rates such as cancer type, time since diagnosis, and duration of clinical examinations. We found 80 published studies originating from 16 cohorts, with median follow-up of 6.0 years (range 3-14). The overall participation rates ranged from 27% to 100%. The highest participation rates were seen in studies of survivors with solid tumors (92%) and the lowest in hematologic malignancies (67%) and central nervous system tumors (73%). The clinical examination in 10 studies (62.5%) lasted for more than 3 hours. Neither duration of the clinical examination nor time since diagnosis seemed to affect the participation rate. We encourage future studies to describe the recruitment process more thoroughly to improve understanding of the factors influencing participation rates.
Databáze: OpenAIRE